We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDT
3226
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$4.16M ﹤0.01%
105,157
-9,424
-8% -$366K
AFI
3227
DELISTED
Armstrong Flooring, Inc.
AFI
$4.14M ﹤0.01%
970,550
-10,644
-1% -$52.1K
KRUS icon
3228
Kura Sushi USA
KRUS
$590M
$4.13M ﹤0.01%
162,238
+65,993
+69% +$1.46M
GYRE icon
3229
Gyre Therapeutics
GYRE
$714M
$4.11M ﹤0.01%
80,440
VBIV
3230
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$4.1M ﹤0.01%
99,051
+9,196
+10% +$201K
LEGH icon
3231
Legacy Housing
LEGH
$687M
$4.08M ﹤0.01%
245,255
+3,392
+1% +$53.2K
CVU icon
3232
CPI Aerostructures
CVU
$68.2M
$4.08M ﹤0.01%
606,169
+79,350
+15% +$584K
PBPB
3233
DELISTED
Potbelly
PBPB
$4.08M ﹤0.01%
965,666
-50,140
-5% -$219K
IBRX icon
3234
ImmunityBio
IBRX
$7.76B
$4.07M ﹤0.01%
1,073,520
+174
+0% +$296
TPST icon
3235
Tempest Therapeutics
TPST
$14.4M
$4.07M ﹤0.01%
3,093
+1,045
+51% +$1.47M
FRAF icon
3236
Franklin Financial Services
FRAF
$283M
$4.06M ﹤0.01%
104,950
+33,151
+46% +$1.21M
AVEO
3237
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$4.04M ﹤0.01%
647,508
+947
+0.1% +$6.97K
LJPC
3238
DELISTED
La Jolla Pharmaceutical Company
LJPC
$4.04M ﹤0.01%
1,027,344
-1,437
-0.1% -$8.49K
GIFI
3239
DELISTED
Gulf Island Fabrication
GIFI
$4.03M ﹤0.01%
795,449
-208,989
-21% -$1.06M
CBNK icon
3240
Capital Bancorp
CBNK
$616M
$4.02M ﹤0.01%
270,187
+154,830
+134% +$2.2M
KALA icon
3241
KALA BIO
KALA
$14.2M
$4.02M ﹤0.01%
436
+21
+5% +$203K
RNET
3242
DELISTED
RigNet, Inc.
RNET
$4.02M ﹤0.01%
608,777
-1,525
-0.2% -$9.15K
ATLO icon
3243
AMES National
ATLO
$278M
$3.98M ﹤0.01%
141,715
-1,441
-1% -$40K
RAPT
3244
DELISTED
RAPT Therapeutics
RAPT
$3.97M ﹤0.01%
+17,965
New +$3.31M
HOV icon
3245
Hovnanian Enterprises
HOV
$789M
$3.96M ﹤0.01%
189,977
+8,272
+5% +$195K
LAKE icon
3246
Lakeland Industries
LAKE
$117M
$3.95M ﹤0.01%
365,909
+27,075
+8% +$291K
VERO
3247
DELISTED
Venus Concept
VERO
$3.93M ﹤0.01%
5,063
+4,821
+1,992% +$4.12M
TACT icon
3248
Transact Technologies
TACT
$58.4M
$3.92M ﹤0.01%
357,773
+5,893
+2% +$67.6K
OPOF
3249
DELISTED
Old Point Financial
OPOF
$3.92M ﹤0.01%
142,637
+17
+0% +$455
AVTX icon
3250
Avalo Therapeutics
AVTX
$989M
$3.92M ﹤0.01%
253
-1
-0.4% -$10.5K

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.